Our read is that alpha-ketoglutarate (AKG) is a well-supported longevity compound that shows promise for extending lifespan and reversing biological age.
Our read is that alpha-ketoglutarate (AKG) is a promising longevity compound that has been successfully reproduced in experiments and is a central metabolite in the TCA and Krebs cycles that declines with age.
Experts suggest that supplementing with AKG may be beneficial, with some reporting it can reduce hair greying, frailty, extend median lifespan, and reverse epigenetic age.
While a controlled clinical trial is underway, preliminary findings and expert use indicate a positive impact in people.
Peter Attia has used a rejuvenant product containing alpha-ketoglutarate (AKG) for years, and some experts mention supplementing 18-month-old female mice with alpha-ketoglutarate and administering it at 1% in drinking water.
Peter Attia notes that a controlled placebo double-blinded clinical trial is being conducted to test time-release AKG for mechanistic information, excluding vitamins. Peter Attia and David Sinclair mention that alpha-ketoglutarate has reports of lifespan extension in yeast, worms, flies, and mice, but has not been tested as extensively as rapamycin. David Sinclair states that alpha-ketoglutarate is a cellular chemical used for amino acid synthesis, energy production, and reversing DNA methylation age. David Sinclair suggests that alpha-ketoglutarate may reprogram biological age.
A controlled placebo double-blinded clinical trial providing definitive mechanistic information on time-release AKG in humans would change the verdict.
Supplementing 18-month-old female mice with alpha-ketoglutarate reduced hair greying, frailty, and extended median lifespan by 10-16%.
Mechanistic and trial evidence converge on a real, replicable effect.
Alpha-ketoglutarate is a promising longevity compound that has been successfully reproduced in experiments.
Alpha-ketoglutarate is a central metabolite in the TCA and Krebs cycles that declines with age and may be beneficial when supplemented.
Supplementing with time-release alpha-ketoglutarate (AKG) has shown in rudimentary methylation clock analyses to reverse epigenetic age by a few years.
Confounding and publication bias inflate the apparent benefit.
Most of the support comes from short or small studies.
Animal-model results don't translate to the human protocol being recommended.
Animal-model results don't translate to the human protocol being recommended.
Most of the support comes from short or small studies.